Re-engineered human T cells effectively target and kill cancerous B cells
Omschrijving
Human white blood cells, engineered to recognize other malignant immune cells, could provide a novel therapy for patients with highly lethal B cell cancers such as acute lymphoblastic leukemia, according to researchers at Memorial Sloan-Kettering Cancer Center. By administering repeated doses of T cells designed to express an artificial receptor which recognizes human B cells, the researchers were able to eradicate cancer in 44 percent of mice bearing human ALL tumors.
[ Ga naar het volledige artikel toe ]
Categorie: kanker

[Reinig uw lichaam met de Chlorella alg -
100% plantaardig ]
|
Het hoofdmenu
Nieuws
Supervoeding
Zoek op
onderwerp
|